IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

241 hedge funds and large institutions have $1.45B invested in Iovance Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 82 increasing their positions, 85 reducing their positions, and 26 closing their positions.

Holders
241
Holders Change
+5
Holders Change %
+2.12%
% of All Funds
4.17%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
82
Reduced
85
Closed
26
Calls
$19.6M
Puts
$3.25M
Net Calls
+$16.4M
Net Calls Change
+$2.37M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$28.7M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$137M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$13.5M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$7.75M
5
FC
5
Finepoint Capital
Massachusetts
$15.2M

Top Sellers

1
FCM
1
Farallon Capital Management
California
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$4.14M
3
State Street
3
State Street
Massachusetts
$95.2M
4
PA
4
Perceptive Advisors
New York
$98.2M
5
Invesco
5
Invesco
Georgia
$931K
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$137M 14,253,754 +890,727 +7%
BlackRock
2
BlackRock
New York
$110M 11,466,492 -104,574 -0.9%
PA
3
Perceptive Advisors
New York
$98.2M 10,248,624 -1,577,675 -13%
State Street
4
State Street
Massachusetts
$95.2M 9,932,152 -1,838,599 -16%
ACA
5
Avoro Capital Advisors
New York
$86.4M 9,020,000 -200,000 -2%
Franklin Resources
6
Franklin Resources
California
$49.6M 5,182,146 +14,639 +0.3%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$45.1M 4,711,314 +360,629 +8%
PAMS
8
Pictet Asset Management (Switzerland)
Switzerland
$38.2M 3,982,344 +349,506 +10%
Goldman Sachs
9
Goldman Sachs
New York
$28.7M 2,994,979 +1,042,633 +53%
Artisan Partners
10
Artisan Partners
Wisconsin
$26.4M 2,758,573 -20,229 -0.7%
Sumitomo Mitsui Trust Group
11
Sumitomo Mitsui Trust Group
Japan
$25.9M 2,699,413 -100,229 -4%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$25.8M 2,695,220 +617,689 +30%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$25.6M 2,672,158 +32,269 +1%
NAMA
14
Nikko Asset Management Americas
New York
$25.2M 2,699,413 -100,229 -4%
CS
15
Credit Suisse
Switzerland
$25M 2,609,705 -28,597 -1%
Ameriprise
16
Ameriprise
Minnesota
$24.1M 2,512,167 -497,847 -17%
AIM
17
ARK Investment Management
Florida
$22.2M 2,317,217 -618,462 -21%
JPMorgan Chase & Co
18
JPMorgan Chase & Co
New York
$20.2M 2,113,278 +71,609 +4%
BC
19
Boxer Capital
California
$18.5M 1,935,133 – –
Balyasny Asset Management
20
Balyasny Asset Management
Illinois
$16.7M 1,743,532 +233,743 +15%
Nuveen Asset Management
21
Nuveen Asset Management
Illinois
$16.7M 1,738,385 -60,164 -3%
6CM
22
683 Capital Management
New York
$16.3M 1,705,000 -295,000 -15%
MB
23
MPM BioImpact
Massachusetts
$16.3M 1,700,000 +500,000 +42%
CS
24
Candriam SCA
Luxembourg
$16M 1,668,920 +40,000 +2%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$15.9M 1,662,513 +415,153 +33%
1
2 3 4 5